Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FQJX3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,332
Award facts
- Contract value 100% obligated
- $19,332.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $19,332.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count unit). The delivery order, awarded on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, indicating the contractor competed successfully in an unrestricted procurement environment. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with a $499.999 billion ceiling under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established as part of a broader $30.3 billion acquisition strategy to supply pharmaceutical products to military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier to the Department of Defense, with documented delivery order activity spanning multiple therapeutic categories and product lines. The company's performance on this and numerous other delivery orders under the PPV-G GEN V contract positions it as a key regional prime vendor contractor supporting the recurring medical supply needs of military healthcare operations globally. The order will be performed at the contractor's location in Park Ridge, Illinois, with funding provided through the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FQJX3?
SPE2DR26FQJX3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQJX3 worth?
The government has obligated $19,332 on SPE2DR26FQJX3.
Is contract SPE2DR26FQJX3 an order under another contract?
Yes. SPE2DR26FQJX3 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJX3 competed?
The extent of competition for SPE2DR26FQJX3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award